Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Trop Anim Health Prod ; 52(5): 2753-2759, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32458353

RESUMO

Natural pastures are the primary sources of feed for ruminant in southwest Nigeria, but they are of poor quality. Oversowing of legumes could augment the nutrients supplied by the poor forages but this is rarely explored. Here, we oversowed two legumes (Stylosanthes guianensis cv. Cook and Stylosanthes hamata cv. Verano) into natural pasture using different tillage methods (zero-tillage and minimal tillage) and sowing methods (broadcast or drill), and examined their macro and trace minerals. We found that the two legumes produced similar (p > 0.05) calcium, phosphorus, and potassium in all treatments, while magnesium and sodium contents significantly differ (p < 0.05). The two legumes were generally rich in macrominerals far beyond the requirements of ruminants and low in trace mineral concentrations irrespective of the treatments imposed. Thus, we recommend oversowing of these two legumes into natural pasture for an adequate supply of major minerals and enhanced livestock productivity in the region of study and beyond. Other sources of trace minerals should be assessed if the natural pasture could not supply them.


Assuntos
Agricultura/métodos , Ração Animal/análise , Fabaceae/química , Oligoelementos/análise , Animais , Cálcio da Dieta/análise , Magnésio/análise , Minerais , Nigéria , Nutrientes , Fósforo/análise
2.
Niger Postgrad Med J ; 15(4): 215-8, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19169336

RESUMO

OBJECTIVES: Aspirin and selenium have been shown in vitro and in vivo to inhibit HIV production through inhibition of the transcription factor, the nuclear factor kappa binding (NF-eB). The aim of this study was to examine the efficacy or otherwise of these drugs in people living with HIV and AIDS (PLWAS) in resource limited countries. PATIENTS AND METHODS: Consenting HAART-naive PLWAS with mean CD4 count of 256.8 +/- 67.6 cells/ul were recruited into the study. Pretherapy blood count, serum biochemistry, chest x-ray, urinary glucose and protein and microscopy and culture of both urine and stool were checked in all cases. Each patient was treated for six months and CD4 counts were repeated at the end of the study. Thirty two patients (23 (72%) females and nine (28%) males), aged 22-52 (median = 36) years were recruited. Twenty-three (72%) were randomised into selenium and aspirin (SAM) and nine (28%) into selenium (SM); multivitamin was added to each arm. RESULTS: Eighteen (56.2%) patients completed the study. Sixteen (88.9%) patients are already on HAART since the termination of the study; one absconded and one died of disease progression. Fourteen (43.8%) of the initial 32 patients dropped out (11 (78.6%) were lost to follow-up, two (14.3%) died and one (7.1%) opted for HAART before completing the study). The post-treatment CD4 count was 293.0 +/-102.2 cells/ml, compared to the pre-therapy mean of 256.8 +/- 67.6 cells/ul, an average rise of 36.2 cells/ul, the difference was not statistically significant (p = 0.059). The post-therapy mean weight was significantly higher than the pretherapy weight, 61.6+/-15.2 kg versus 60.0+/-14.3 kg (p = 0.015). CONCLUSION: The SAM/SM combination regimen improved the quality of life of PLWAS, however, a greater number of patients and a longer period of follow up, are necessary to arrive at a more meaningful conclusion.


Assuntos
Síndrome da Imunodeficiência Adquirida/tratamento farmacológico , Fármacos Anti-HIV/farmacologia , Aspirina/farmacologia , Infecções por HIV/tratamento farmacológico , HIV-1/efeitos dos fármacos , Selênio/farmacologia , Síndrome da Imunodeficiência Adquirida/virologia , Adulto , Fármacos Anti-HIV/uso terapêutico , Aspirina/uso terapêutico , População Negra , Peso Corporal , Contagem de Linfócito CD4 , Quimioterapia Combinada , Feminino , Infecções por HIV/virologia , HIV-1/genética , Humanos , Masculino , Pessoa de Meia-Idade , Nigéria , Selênio/uso terapêutico , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa